Estimation of insulin like growth Factor-1 (IGF-1) and other biochemical parameters in nephropathy patients

A major consequence of diabetes (type 2) is diabetic nephropathy and its leading cause of chronic kidney disease. This study was amid to determination of insulin like growth factor −1 in diabetic nephropathy patients and its relation with other biochemistry. This study was carried out at the National Diabetes Center/ Mustansiriyah University during the period from 1/11/2020 to 30/3/2021. A highly significant increase of serum fasting blood sugar, total cholesterol, triglyceride, low density lipoprotein, and insulin like growth factor −1 in Nephropathy with Diabetes Mellitus when compared with Nephropathy without Diabetes Mellitus and highly significant decrease of glomerular filtration rate in Nephropathy with Diabetes Mellitus when compared with Nephropathy without Diabetes Mellitus. as Higher serum levels of fasting blood sugar, hypertension, and disturbances in lipid profile and kidney function are found in nephropathy with diabetes mellitus patients. Lower serum insulin like growth factor −1 levels were found to be positively linked with diabetic nephropathy. We propose that serum insulin like growth factor −1 levels be included in routine nephropathy studies in diabetic individuals.